SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Briley M., Fillion G. New Concepts in Depression. Macmillan Press, Houndmills , 1988.
  • 2
    Howells JG. Modern Perspectives in the Psychiatry of the Affective Disorders. Brunner/Mazel Publishers, New York , 1989.
  • 3
    Matussek N. Catecholamines and mood: Neuroendocrine aspects. In: FuxeK., GantenD., PfaffD., Neuroendocrinology of Mood. Springer Verlag, Berlin , 1988; 141182.
  • 4
    Nakagawara M., Shioe K., Hirano M., Sato Y. β-phenylethylamine, neuropeptide Y and noradrenergic function in depression. In: KariyaT., NakagawaraM., Affective Disorders: Perspectives on Basic Research and Clinical Practice. Seiwa Publishing Company, Tokyo , 1991; 3344.
  • 5
    Siever LJ. Role of noradrenergic mechanisms in the etiology of the affective disorders. In: MeltzerHY., Psychopharmacology: The Third Generation of Progress. Raven Press, New York , 1987; 493504.
  • 6
    Trimble MR. Biological Psychiatry, 2nd edn. John Wiley & Sons Ltd, Chichester , 1996.
  • 7
    Sack DA., Rosenthal NE., Parry BL., Wehr TA. Biological rhythms in psychiatry. In: MeltzerHY., Psychopharmacology: The Third Generation of Progress. Raven Press, New York , 1987; 493504.
  • 8
    Price LH., Charney DS., Rubin AL., Heninger GR. α 2-adrenergic receptor function in depression. Arch. Gen. Psychiatry 1986; 43: 849858.
  • 9
    Minuth M., Jakobs KH. Alpha 2-adrenoceptors in platelets of spontaneously hypertensive rats. Naunym-Schmiedebergs Arch., Pharmacol. 1983; 322: 98103.
  • 10
    Stock JM., U'Prichard DC., Fuxe K. Epinephrine in the Central Nervous System. Oxford University Press, New York , 1988.
  • 11
    U'Prichard DC. Biochemical characteristics and regulation of brain α 2-adrenoceptors. In: Salama AI., Presynaptic Modulation of Postsynaptic Receptors in Mental Diseases. Ann. NY Acad. Sci. 1984; 430: 5575.
  • 12
    Palermo A., Costantini C., Mara G., Libretti A. Role of the sympathetic nervous system in spontaneous hypertension: Changes in central adrenoceptors and plasma catecholamine levels. Clin. Sci. 1981; 61: 195198.
  • 13
    Saavedra JM., Grobecker H., Axelrod J. Adrenaline-forming enzyme in brainstem: Elevation in genetic and experimental hypertension. Science 1976; 191: 483484.
  • 14
    Brown GW., Harris TO. Depression. In: BrownGW., HarrisTO., Life Events and Illness. Unwin Hyman Ltd, London , 1989.
  • 15
    Lange J. Die endogenen und reaktiven Gem tserkrankungen und die manisch-depressive Konstitution. In: BumkeO., Lehrbuch der Geisteskrankheiten 6. Springer, Berlin , 1928; 1231 (in German).
  • 16
    Par WP. Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiol. Behav. 1989; 46: 993998.
  • 17
    Klumann R. Psychosomatische Medizin. Springer-Verlag, Berlin , 1986.
  • 18
    Nakagawara M., Witzke W., Matussek N. Hypertension and depression. Psychiat. Res. 1987; 21: 8586.
  • 19
    Green AR., Costain DW. Pharmacology and Biochemistry of Psychiatric Disorders. John Wiley & Sons, Chichester , 1981.
  • 20
    Martire M., Pistritto G., Preziosi P. Reduced inhibitory effects of clonidine and neuropeptide Y on 3H-noradrenaline release in synaptosomes of spontaneously hypertensive rats. Pharmacol. Res. 1989; 21: 653654.
  • 21
    Golda V., Petr R. Behaviour of genetically hypertensive rats in an animal model of depression and in an animal model of anxiety. Activ. Nerv. Sup. 1986; 28: 274275.
  • 22
    Middeke M. Adrenoceptors in hypertension. In: MiddekeM., HolzgreveH., New Aspects in Hypertension: Adrenoceptors. Springer-Verlag, Berlin , 1986; 103116.
  • 23
    Nakagawara M. The effect of phenylethanolamine-N-methyltransferase inhibitor on locomotor activity in rats: The role of central α 2-adrenoceptor and PNMT activity. In: Bunney, WE.Jr. Hippius, H., LaakmannG., SchmauM., Neuropsychopharmacology. Springer-Verlag, Berlin , 1990; 277285.